跳至主要内容
临床试验/CTRI/2021/06/034453
CTRI/2021/06/034453尚未招募4 期

A STUDY OF EFFICACY AND SAFETY OF PREGABALIN COMPARE TO DULOXETINE IN NEUROPATHIC PAIN AMONG PATIENTS WITH PROLAPSED INTER VERTEBRAL DISC IN A TEACHING HOSPITAL: - AN OPEN LABEL NON RANDOMISED CONTROL TRIAL.

Agartala government medical college0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 18 years and above, all clinically diagnosed cases of neuropathic pain due to PIVD and who will be prescribed either Pregabalin or Duloxetine and fulfill the following criteria
  • a) Patients whose visual analogue scale >4.
  • b) Patients having DN4 questionnaires score >4.
  • c) Leeds assessment of neuropathic symptoms and sign (LANSS) >12

排除标准

  • a) Neuropathic pain due to other co-morbidities e.g. (Peripheral Neuropathy, Alcoholic, Cancer).
  • b) Pregnancy and lactation.
  • c) Mental disorder.
  • d) Those who are receiving herbal medicine and homeopathy or any other medicine having pain modulator properties except NSAIDS.
  • e) Those who taken Pregabalin / Gabapentin or Duloxetine prior to the study

研究者

发起方
Agartala government medical college

相似试验